Methotrexate's First Evidence of Disease Modification in Pre-RA
Short-term methotrexate used in patients with arthralgia sustainably reduced disease burden and inflammation on MRI in all at-risk groups, according to the first data on pre-RA disease modification.
Source: medscape.com